The DOI matches its Crossref record.
Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease
Abstract
S ummary. Factor VIII was purified from cryoprecipitate by ion exchange chromatography on solid phase polyelectrolyte E‐5 (PE‐E5). The product was highly purified (3.5 u VIII: C/mg protein) compared to conventional concentrate (0.3 u VIII: C/mg protein) with low fibrinogen, low isoagglutinin titre, and a ratio of factor VIII coagulant activity (VIII: C) to factor VIII related antigen (VIIIR: Ag) of 16:1. Trial infusions of this material (PE VIII) were given to three patients with severe haemophilia A and one patient with homozygous von Willebrand's disease. These patients also each received separate infusions of intermediate purity concentrate (IPC) for comparison. There were no adverse effects. The mean half life of VIII: C after PE VIII infusion in the haemophiliacs was 10.9 h and after IPC was 12.1 h, a statistically insignificant difference. The survival of factor VIII coagulant antigen (VIII:CAg) was similar to that of VIII:C. In contrast, the half life of VIII:C and of VIII:CAg was very short after infusion of PE VIII in the patient with von Willebrand's disease (2.4 h). IPC when infused in this patient produced a typical secondary rise of VIII:C. Two bleeding episodes in severe haemophiliacs were satisfactorily treated with PE VIII. PE‐E5 deserves further study as a means of preparing clinical concentrates of factor VIII.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Impact, Diagnosis and Treatment of von Willebrand Disease
Sadler, J. E., Berntorp, E., Bochkov, N., Boulyjenkov, V., Ginsburg, D., Meyer, D., Peake, I., Rodeghiero, F., Srivastava, A., & Mannucci, P. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613992 · Cited by 501
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
Lenting, P. J., van Mourik, J. A., & Mertens, K. (1998) · Blood · doi:10.1182/blood.v92.11.3983 · Cited by 451
Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.
Kaufman, R. J., Wasley, L. C., & Dorner, A. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68793-9 · Cited by 380
Endothelial cells and coagulation
Neubauer, K., & Zieger, B. (2022) · Cell and Tissue Research · doi:10.1007/s00441-021-03471-2 · Cited by 351
Cloning and characterization of two cDNAs coding for human von Willebrand factor.
Sadler, J. E., Shelton-Inloes, B. B., Sorace, J. M., Harlan, J. M., Titani, K., & Davie, E. W. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6394 · Cited by 302
Metadata
- Authors
- Tuddenham, E. G. D., Lane, R. S., Rotblat, F., Johnson, A. J., Snape, T. J., Middleton, S., & Kernoff, P. B. A.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1982-10
- Volume
- 52
- Issue
- 2
- Pages
- 259-267
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2005268147
- Cited by
- 171
- References
- 0
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. https://app.cochat.ai/papers/10.1111/j.1365-2141.1982.tb03888.x
- The paper
- Tuddenham, E. G. D., Lane, R. S., Rotblat, F., Johnson, A. J., Snape, T. J., Middleton, S., & Kernoff, P. B. A. (1982). Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1982.tb03888.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.